Stock screener

ALNY

Conviction 14HealthcareScan · Thu, Sep 24, 2026

Alnylam Pharmaceuticals, Inc. (ALNY) closed at $249.76 (+1.32%) on Sep 24, 2026. Price is above its 50-day and below its 200-day moving average. RSI(14) 52, RS Rating 10, -49.2% from its 52-week high, -37.6% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

ALNY$249.76+1.32%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
Cory A Booker
Vol MA14 1.48M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
ALNYLAM PHARMACEUTICALS, INC.PHARMACEUTICAL PREPARATIONSwww.alnylam.com ↗
Price249.76
Change+1.32%
Gap+1.06%
Rel volume0.96×
Avg volume1.62M
Avg $ vol405.38M
SMA 20248.88
SMA 50244.84
SMA 200307.82
Price vs 50+2.01%
Price vs 200-18.86%
MA stackmixed
50/200 cross—
Supertrendup · 231.06
RSI (14)52
MACD hist0.08
MACD crossbull · 0d
Stoch %K / %D38 / 37
ADX (14)12
+DI / −DI22 / 17
RSI divergence—
MACD divergence—
ATR %4.04%
ADR %4.08%
52w high491.22
52w low205.48
From 52w high-49.16%
Above 52w low+21.55%
New 52w highNo
SqueezeOff
Bollinger width15.24%
%B0.52
Donchian pos53.95%
Donchian high272.08
Donchian low223.61
AVWAP (52w high)319.95
vs AVWAP high-21.94%
AVWAP (52w low)232.26
vs AVWAP low+7.54%
OBV trendFlat
Chaikin MF (20)0.09
Today vs 20d0.96×
Avg vol (14d)1.48M
Avg vol (20d)1.62M
Avg $ vol (20d)405.38M
Market cap33.42B
RS Rating10 / 99
RS 3m (vs SPY)-19.30%
RS 6m (vs SPY)-40.83%
RS line new highNo
Trend template1/8
Technical rank42.5
1 week+1.73%
1 month+4.03%
3 months-14.81%
6 months-24.02%
1 year-45.04%
YTD-37.59%
P/E106.52
P/B24.68
P/S9.00
P/FCF71.81
EPS2.33
Div yield—
ROE23.17%
ROA5.64%
Debt/Eq0.50
Current3.05
EV/EBITDA62.90
Gross margin—
Net margin8.45%
Rev growth65.19%
EPS growth212.79%
Price target377.31
Target upside51.07%
Analyst ratingBuy
Institutional110.95%
Ent. value32.39B
Revenue1.29B
Net income164.49M
Gross profit—
Free cash flow465.38M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out133.51M
Employees2.5K
ListedFri, May 28, 2004
Free float132.42M
Float %99.9%
Short interest6.34M
Days to cover3.9d
Short volume75.0%
Squeeze score49 / 100
Next earnings—
EPS forecast—
Last EPS vs est$1.21 vs $1.44
Last surprise-16.0% miss
Setup gradeD
Conviction14 / 100
Pattern quality—
Tech rank42.5 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance263.80
Support217.05
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Recent news

Congress activity

Disclosed STOCK Act trades in ALNY · 2 recent

All disclosures →
MemberSideAmount
Cory A Booker
Cory A Booker
senate · D · NJ · traded 2026-08-11
Sell$1K–$15K
Jefferson Shreve
Jefferson Shreve
house · R · IN · traded 2025-05-12
Sell$15K–$50K

Insider activity

SEC Form 4 transactions in ALNY · open-market 5 sells

InsiderSideShares
PYOTT DAVID E I
Director · Common Stock · 2026-06-01
Sell495
PYOTT DAVID E I
Director · Common Stock · 2026-06-01
Other—
PYOTT DAVID E I
Director · Common Stock · 2026-06-01
Sell17
PYOTT DAVID E I
Director · Common Stock · 2026-06-01
Sell1.18K
PYOTT DAVID E I
Director · Common Stock · 2026-06-01
Exercise3.83K
PYOTT DAVID E I
Director · Stock Option (Right to Buy) · 2026-06-01
Exercise3.83K
PYOTT DAVID E I
Director · Common Stock · 2026-06-01
Sell1.22K
Cravatt Benjamin
Director · Stock Option (Right to Buy) · 2026-06-01
Grant4.39K
PYOTT DAVID E I
Director · Common Stock · 2026-06-01
Sell921
Sigal Charles Elliott
Director · Common Stock · 2026-05-20
Other—

SEC filings

EDGAR filings in ALNY · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.